Modulation of the immune system in the mouse. 2. Drug administration following antigen sensitization
- 1 April 1980
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 10 (1-2) , 48-56
- https://doi.org/10.1007/bf02024178
Abstract
The effects of administering drugs 2 days after antigen sensitization in a combined model of delayed type hypersensitivity (DTH) and humoral immunity (HI) in the mouse are described and compared with a previous study in which drugs were administered prior to sensitization using the same model. Low doses of cyclophosphamide (CY) administered after antigen sensitization were found to enhance DTH to methylated bovine serum albumin (MBSA). In addition, high doses of this drug suppressed DTH for 3 days after challenge, and then enhanced the response for a further 5 days. The HI response to sheep red blood cells (SRBC) was simultaneously suppressed by a range of CY doses. A number of different drug types demonstrated a similar pattern of dose-dependent DTH effects. However, unlike the previous study DTH enhancement was not confined to the alkylating agents. Either DTH enhancement or suppression was also observed after treatment with a number of other drugs. HI was suppressed by several drugs, in particular by a number of alkylating agents and anti-metabolites. Selective effects on one or other limbs of the immune response were observed. The mode(s) of action of drugs active in the present study are uncertain but possible explanations are discussed in terms of the elimination and subsequent recovery of specific cell populations.Keywords
This publication has 37 references indexed in Scilit:
- INHIBITION OF ANTIBODY FORMATION BY PREDNISOLONE: LOCATION OF A SHORT SENSITIVE PERIODActa Pathologica Microbiologica Scandinavica, 2009
- Modulation of the immune system in the mouse 1. Drug administration prior to antien sensitizationInflammation Research, 1980
- Induction of delayed hypersensitivity to protein antigens in mice without Freund adjuvantsJournal of Allergy and Clinical Immunology, 1977
- Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in miceNature, 1976
- Selective Suppression of Humoral Immunity by Antineoplastic DrugsAnnual Review of Pharmacology and Toxicology, 1976
- Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.The Journal of Experimental Medicine, 1975
- B-cell suppression of delayed hypersensitivity reactionsNature, 1974
- Die Überwachung des SchrittmacherpatientenBiomedizinische Technik/Biomedical Engineering, 1973
- Cellular Hypersensitivity and Immunity (Part 1 of 3)Published by S. Karger AG ,1972
- Effect of Cyclophosphoramide, 6-Mercaptopurine, Actinomycin D and Vincaleukoblastine on the Acquisition of Delayed Hypersensitivity (DNCB Contact Dermatitis) in the Guinea-Pig11From the Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia 4, Pennsylvania.This study was supported in part by U.S.P.H.S. Training Grant 2 G-62.This investigation was carried out during the tenure of a postdoctoral fellowship, held by Dr. Maibach, from the Division of General Medical Sciences, United States Public Health Service.Cyclophosphoramide (Cytoxan®) was supplied by Paul A. Walter, M.D., Mead Johnson Laboratories, Evansville 21, Indiana; 6-mercaptopurine by Donald S. Searle, M.D., Burroughs Wellcome & Co., Tuckahoe, N.Y.; vincaleukoblastine by J. A. Armstrong, M.D., Eli Lilly and Co., Indianapolis 6, Indiana; and Actinomycin D by Elmer Alpert, M.D., Merck Sharp and Dohme, West Point, Pa.Presented at the Twenty-second Annual Meeting of The Society for Investigative Dermatology, Inc., New York, N.Y., June 28, 1961.Journal of Investigative Dermatology, 1961